These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 21880586

  • 1. Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation.
    Chen YB, Driscoll JP, McAfee SL, Spitzer TR, Rosenberg ES, Sanders R, Moss RB, Fang F, Marty FM.
    Clin Infect Dis; 2011 Oct; 53(7):e77-80. PubMed ID: 21880586
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center.
    Salvatore M, Satlin MJ, Jacobs SE, Jenkins SG, Schuetz AN, Moss RB, Van Besien K, Shore T, Soave R.
    Biol Blood Marrow Transplant; 2016 May; 22(5):965-70. PubMed ID: 26904972
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality.
    Dignan F, Alvares C, Riley U, Ethell M, Cunningham D, Treleaven J, Ashley S, Bendig J, Morgan G, Potter M.
    J Hosp Infect; 2006 Aug; 63(4):452-8. PubMed ID: 16772104
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment.
    Elizaga J, Olavarria E, Apperley J, Goldman J, Ward K.
    Clin Infect Dis; 2001 Feb 01; 32(3):413-8. PubMed ID: 11170949
    [Abstract] [Full Text] [Related]

  • 10. DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation.
    Chalkias S, Mackenzie MR, Gay C, Dooley C, Marty FM, Moss RB, Li T, Routh RL, Walsh SR, Tan CS.
    Transpl Infect Dis; 2014 Feb 01; 16(1):141-4. PubMed ID: 24383501
    [Abstract] [Full Text] [Related]

  • 11. Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy.
    Chakrabarti S, Collingham KE, Holder K, Oyaide S, Pillay D, Milligan DW.
    Clin Infect Dis; 2000 Dec 01; 31(6):1516-8. PubMed ID: 11096028
    [Abstract] [Full Text] [Related]

  • 12. A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.
    Hodson A, Kasliwal M, Streetly M, MacMahon E, Raj K.
    Bone Marrow Transplant; 2011 Dec 01; 46(12):1545-50. PubMed ID: 21258418
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient.
    Shima T, Yoshimoto G, Nonami A, Yoshida S, Kamezaki K, Iwasaki H, Takenaka K, Miyamoto T, Harada N, Teshima T, Akashi K, Nagafuji K.
    Int J Hematol; 2008 Oct 01; 88(3):336-340. PubMed ID: 18712461
    [Abstract] [Full Text] [Related]

  • 14. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study.
    Chemaly RF, Marty FM, Wolfe CR, Lawrence SJ, Dadwal S, Soave R, Farthing J, Hawley S, Montanez P, Hwang J, Ho JH, Lewis S, Wang G, Boeckh M.
    Clin Infect Dis; 2021 Aug 02; 73(3):e773-e781. PubMed ID: 33569576
    [Abstract] [Full Text] [Related]

  • 15. Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients.
    Maziarz RT, Sridharan P, Slater S, Meyers G, Post M, Erdman DD, Peret TC, Taplitz RA.
    Biol Blood Marrow Transplant; 2010 Feb 02; 16(2):192-8. PubMed ID: 19781656
    [Abstract] [Full Text] [Related]

  • 16. Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomes.
    Seo S, Xie H, Karron RA, Thumar B, Englund JA, Leisenring WM, Stevens-Ayers T, Boeckh M, Campbell AP.
    Bone Marrow Transplant; 2014 Sep 02; 49(9):1205-11. PubMed ID: 24978141
    [Abstract] [Full Text] [Related]

  • 17. Parainfluenza virus 3 pneumonia in a kidney transplant recipient.
    Park SY, Sung H, Park KT, Kim SC, Kim SH, Choi SH, Kim YS, Woo JH, Lee SO, Han DJ.
    Transpl Infect Dis; 2009 Aug 02; 11(4):333-6. PubMed ID: 19356218
    [Abstract] [Full Text] [Related]

  • 18. Human parainfluenza type 4 virus (hPIV4) infection provoking many questions regarding the role of this virus as the causative agent of respiratory tract infections in the post-transplant setting.
    Hohenthal U, Nikoskelainen J, Vainionpää R, Peltonen R, Routamaa M, Itälä M, Kotilainen P.
    Bone Marrow Transplant; 2002 Apr 02; 29(7):629-30. PubMed ID: 11979316
    [No Abstract] [Full Text] [Related]

  • 19. Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis.
    Butnor KJ, Sporn TA.
    Arch Pathol Lab Med; 2003 Feb 02; 127(2):235-8. PubMed ID: 12562244
    [Abstract] [Full Text] [Related]

  • 20. Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding.
    Tabatabai J, Schnitzler P, Prifert C, Schiller M, Weissbrich B, von Lilienfeld-Toal M, Teschner D, Jordan K, Müller-Tidow C, Egerer G, Giesen N.
    PLoS One; 2022 Feb 02; 17(7):e0271756. PubMed ID: 35905071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.